Skip to main content

March 2024 Vol 17, No 2

Teresa Macarulla, MD, PhD, presented the results of 2 phase 1a/1b dose-escalation/expansion trials, studies that measured the efficacy and safety of brigimadlin in patients with advanced biliary tract cancer. Read More ›

Zongli Zhang, MD, PhD, presented the preliminary results of an ongoing single-arm, multicenter, open-label, real-world study analyzing the efficacy and safety of surufatinib as a second-line treatment option for patients with biliary tract cancer. Read More ›

Colorectal cancer (CRC) is the second most common cause of cancer-related death in the United States and is the leading cause of death in men aged <50 years. Read More ›

An important and inspiring documentary on Dr. Carl June’s quest to cure cancer, CAR T-cell therapy, and his first pediatric patient. Read More ›